Drug:
Reaction: DEVICE MALFUNCTION
20260101 - 20261231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 26880348 |
US |
1 | |
Product prescribing issue, Drug dose omission by device, Wrong technique in product usage process, Device malfunction, Device delivery system issue, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE, |
||||
| 402 | 26880382 |
US |
79 | 2 |
Wrong technique in product usage process, Device malfunction, Device delivery system issue, Device issue, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE, |
||||
| 403 | 26880734 |
US |
54 | |
Product dose omission issue, Device malfunction, Device leakage, |
||||
| 404 | 26880739 |
US |
49 | 1 |
Injection site haemorrhage, Device leakage, Injection site indentation, Injection site bruising, Product dose omission issue, Device malfunction, |
||||
| 405 | 26880740 |
US |
2 | |
Injection site pain, Injection site haemorrhage, Device malfunction, |
||||
| 406 | 26880744 |
US |
56 | 1 |
Device malfunction, Incorrect dose administered by device, |
||||
| 407 | 26880748 |
US |
76 | 2 |
Product dose omission issue, Device malfunction, Product storage issue, |
||||
ORAL SEMAGLUTIDE, |
||||
| 408 | 26880749 |
US |
2 | |
Drug dose omission by device, Device leakage, Device malfunction, |
||||
ORAL SEMAGLUTIDE, |
||||
| 409 | 26880754 |
US |
55 | |
Device malfunction, Drug dose omission by device, |
||||
| 410 | 26880755 |
US |
62 | 2 |
Blood glucose increased, Device malfunction, |
||||
INSULIN ASPART, INSULIN GLARGINE, |
||||
| 411 | 26880758 |
US |
64 | |
Product dose omission issue, Device malfunction, |
||||
ORAL SEMAGLUTIDE, |
||||
| 412 | 26880759 |
US |
64 | |
Injection site indentation, Injection site discharge, Product dose omission issue, Device malfunction, |
||||
| 413 | 26880762 |
US |
55 | |
Injection site pain, Device malfunction, |
||||
| 414 | 26880765 |
US |
47 | 2 |
Drug dose omission by device, Device malfunction, Device leakage, |
||||
| 415 | 26880766 |
US |
68 | 1 |
Injection site haemorrhage, Device malfunction, Incorrect dose administered by device, |
||||
| 416 | 26880767 |
US |
56 | |
Drug dose omission by device, Device malfunction, |
||||
ORAL SEMAGLUTIDE, |
||||
| 417 | 26880769 |
US |
||
Device malfunction, Product storage issue, |
||||
INSULIN DEGLUDEC, |
||||
| 418 | 26880770 |
US |
48 | 2 |
Device malfunction, Injection site urticaria, Injection site pain, Injection site swelling, Device leakage, Injection site discharge, Incorrect dose administered by product, Injection site bruising, |
||||
| 419 | 26880771 |
US |
||
Device malfunction, Device use error, Injury associated with device, Product dose omission in error, |
||||
ORAL SEMAGLUTIDE, |
||||
| 420 | 26880772 |
US |
63 | 1 |
Product dose omission issue, Device malfunction, |
||||
ORAL SEMAGLUTIDE, |
||||
| 421 | 26880773 |
US |
45 | 2 |
Incorrect dose administered by device, Device malfunction, Device leakage, |
||||
| 422 | 26880775 |
US |
||
Incorrect dose administered by device, Device leakage, Device malfunction, |
||||
INSULIN DEGLUDEC AND LIRAGLUTIDE, |
||||
| 423 | 26880776 |
US |
42 | 2 |
Device use error, Device malfunction, |
||||
| 424 | 26880777 |
US |
79 | 2 |
Drug dose omission by device, Device malfunction, |
||||
INSULIN DEGLUDEC, |
||||
| 425 | 26880778 |
US |
||
Incorrect dose administered by product, Accidental exposure to product, Device defective, Device malfunction, Device leakage, Device mechanical issue, |
||||
| 426 | 26880779 |
US |
42 | 2 |
Product dose omission issue, Device leakage, Device malfunction, |
||||
| 427 | 26880781 |
US |
||
Device use error, Device malfunction, |
||||
| 428 | 26880783 |
US |
81 | 1 |
Injection site discharge, Device malfunction, |
||||
| 429 | 26880784 |
US |
53 | 1 |
Device malfunction, Injection site pain, Injury associated with device, Injection site bruising, |
||||
| 430 | 26880786 |
US |
40 | 2 |
Injection site haemorrhage, Device malfunction, |
||||
| 431 | 26880791 |
US |
||
Accidental exposure to product, Device malfunction, Exposure via mucosa, |
||||
| 432 | 26880793 |
US |
1 | |
Wrong technique in device usage process, Device malfunction, |
||||
ORAL SEMAGLUTIDE, |
||||
| 433 | 26880794 |
US |
1 | |
Product storage issue, Device malfunction, |
||||
ORAL SEMAGLUTIDE, |
||||
| 434 | 26880795 |
US |
||
Device leakage, Device malfunction, Drug dose omission by device, |
||||
| 435 | 26880797 |
US |
60 | 2 |
Device malfunction, Injection site pain, |
||||
ORAL SEMAGLUTIDE, |
||||
| 436 | 26880802 |
US |
2 | |
Device malfunction, Drug dose omission by device, |
||||
ORAL SEMAGLUTIDE, |
||||
| 437 | 26880803 |
US |
64 | 2 |
Device malfunction, Injection site haemorrhage, Accidental exposure to product, Device leakage, |
||||
| 438 | 26880805 |
US |
2 | |
Injury associated with device, Incorrect dose administered by product, Device malfunction, Injection site indentation, |
||||
| 439 | 26880807 |
US |
64 | 1 |
Drug dose omission by device, Device malfunction, |
||||
ORAL SEMAGLUTIDE, |
||||
| 440 | 26880808 |
US |
2 | |
Injection site haemorrhage, Device leakage, Device malfunction, Drug dose omission by device, Injection site bruising, |
||||
| 441 | 26880809 |
US |
2 | |
Wrong technique in product usage process, Device malfunction, Device leakage, |
||||
INSULIN ASPART, |
||||
| 442 | 26880810 |
US |
39 | 1 |
Drug dose omission by device, Device malfunction, |
||||
ORAL SEMAGLUTIDE, |
||||
| 443 | 26880814 |
US |
1 | |
Incorrect dose administered by product, Device malfunction, |
||||
| 444 | 26880815 |
US |
2 | |
Drug dose omission by device, Device malfunction, |
||||
| 445 | 26880818 |
US |
||
Device malfunction, Incorrect dose administered by product, |
||||
| 446 | 26880819 |
US |
1 | |
Product dose omission issue, Device malfunction, Device leakage, |
||||
| 447 | 26880820 |
US |
||
Injection site indentation, Injection site pain, Device malfunction, |
||||
| 448 | 26880824 |
US |
61 | 1 |
Injection site pain, Device malfunction, Device leakage, |
||||
| 449 | 26880826 |
US |
2 | |
Product dose omission issue, Device malfunction, |
||||
| 450 | 26880827 |
US |
47 | 2 |
Device malfunction, Injection site swelling, Device leakage, Device difficult to use, Incorrect dose administered by device, |
||||
| 451 | 26880828 |
US |
2 | |
Device malfunction, Wrong technique in product usage process, Off label use, |
||||
ORAL SEMAGLUTIDE, |
||||
| 452 | 26880831 |
US |
||
Product dose omission issue, Device malfunction, Device leakage, |
||||
| 453 | 26880832 |
US |
2 | |
Product dose omission issue, Device malfunction, |
||||
| 454 | 26880833 |
US |
||
Product dose omission issue, Device malfunction, Device leakage, |
||||
| 455 | 26880834 |
US |
2 | |
Injection site indentation, Device malfunction, Accidental exposure to product, Injection site discharge, |
||||
| 456 | 26880836 |
US |
2 | |
Injection site pain, Device malfunction, Device deployment issue, |
||||
| 457 | 26880839 |
US |
55 | |
Incorrect dose administered by device, Device malfunction, Device leakage, |
||||
| 458 | 26880840 |
US |
57 | 1 |
Device leakage, Incorrect dose administered, Injection site erythema, Device malfunction, |
||||
| 459 | 26880843 |
US |
2 | |
Device malfunction, Product dose omission issue, |
||||
| 460 | 26880844 |
US |
2 | |
Injection site haemorrhage, Device malfunction, Device leakage, |
||||
| 461 | 26880845 |
US |
||
Injection site inflammation, Incorrect dose administered by product, Device malfunction, Accidental exposure to product, |
||||
| 462 | 26880847 |
US |
89 | 1 |
Drug dose omission by device, Device malfunction, |
||||
ORAL SEMAGLUTIDE, |
||||
| 463 | 26880849 |
US |
70 | |
Product dose omission issue, Device malfunction, |
||||
ORAL SEMAGLUTIDE, |
||||
| 464 | 26880850 |
US |
||
Injection site discharge, Device malfunction, |
||||
| 465 | 26880852 |
US |
59 | 2 |
Incorrect dose administered, Device malfunction, Device leakage, |
||||
| 466 | 26880853 |
US |
||
Incorrect dose administered by device, Device malfunction, Device leakage, Device malfunction, |
||||
| 467 | 26880856 |
US |
||
Device malfunction, Product dose omission issue, |
||||
ORAL SEMAGLUTIDE, |
||||
| 468 | 26880859 |
US |
||
Injection site haemorrhage, Device malfunction, |
||||
| 469 | 26880861 |
US |
||
Product dose omission issue, Device leakage, Device malfunction, |
||||
| 470 | 26880864 |
US |
||
Injection site bruising, Device leakage, Device malfunction, |
||||
| 471 | 26880866 |
US |
2 | |
Product dose omission issue, Device malfunction, Device leakage, |
||||
| 472 | 26880868 |
US |
51 | 2 |
Device malfunction, Injection site bruising, Drug dose omission by device, Device leakage, |
||||
| 473 | 26880871 |
US |
38 | 1 |
Injury associated with device, Device malfunction, Drug dose omission by device, Injection site indentation, |
||||
| 474 | 26880872 |
US |
2 | |
Product dose omission issue, Device malfunction, |
||||
ORAL SEMAGLUTIDE, |
||||
| 475 | 26880873 |
US |
51 | 1 |
Injection site erythema, Device malfunction, Device leakage, |
||||
| 476 | 26880874 |
US |
1 | |
Device malfunction, Incorrect dose administered by device, Wrong technique in device usage process, |
||||
ORAL SEMAGLUTIDE, |
||||
| 477 | 26880875 |
US |
62 | |
Product dose omission issue, Device malfunction, |
||||
ORAL SEMAGLUTIDE, |
||||
| 478 | 26880876 |
US |
2 | |
Device malfunction, Product dose omission issue, |
||||
ORAL SEMAGLUTIDE, |
||||
| 479 | 26880877 |
US |
||
Drug dose omission by device, Device malfunction, Injection site discharge, |
||||
| 480 | 26880878 |
US |
||
Incorrect dose administered by product, Device malfunction, |
||||
| 481 | 26880880 |
US |
62 | 2 |
Drug dose omission by device, Device malfunction, Device use error, |
||||
| 482 | 26880882 |
US |
1 | |
Device malfunction, Accidental exposure to product, |
||||
| 483 | 26880884 |
US |
55 | |
Injection site bruising, Device malfunction, Device leakage, Drug dose omission by device, |
||||
| 484 | 26880885 |
US |
42 | 2 |
Device malfunction, Product dose omission issue, |
||||
ORAL SEMAGLUTIDE, |
||||
| 485 | 26880887 |
US |
2 | |
Injection site pain, Device malfunction, Device leakage, |
||||
| 486 | 26880888 |
US |
1 | |
Drug dose omission by device, Device malfunction, |
||||
ORAL SEMAGLUTIDE, |
||||
| 487 | 26880889 |
US |
||
Device malfunction, Drug dose omission by device, |
||||
| 488 | 26880891 |
US |
59 | |
Product dose omission issue, Device malfunction, |
||||
ORAL SEMAGLUTIDE, |
||||
| 489 | 26880892 |
US |
2 | |
Product dose omission issue, Device malfunction, |
||||
ORAL SEMAGLUTIDE, |
||||
| 490 | 26880893 |
US |
1 | |
Drug dose omission by device, Injury associated with device, Device malfunction, |
||||
ORAL SEMAGLUTIDE, |
||||
| 491 | 26880894 |
US |
1 | |
Drug dose omission by device, Device leakage, Device malfunction, |
||||
ORAL SEMAGLUTIDE, |
||||
| 492 | 26880896 |
US |
2 | |
Injection site bruising, Injection site indentation, Injection site haemorrhage, Device malfunction, |
||||
| 493 | 26880897 |
US |
40 | 1 |
Injection site pain, Device leakage, Device malfunction, |
||||
| 494 | 26880898 |
US |
2 | |
Product dose omission issue, Device malfunction, |
||||
| 495 | 26880899 |
US |
77 | 1 |
Injection site indentation, Injection site pain, Device malfunction, Device leakage, |
||||
| 496 | 26880900 |
US |
||
Injection site discharge, Device malfunction, Incorrect dose administered by device, |
||||
| 497 | 26880901 |
US |
36 | 2 |
Nausea, Incorrect dose administered by device, Device malfunction, |
||||
| 498 | 26880902 |
US |
2 | |
Incorrect dose administered by product, Device leakage, Device malfunction, |
||||
| 499 | 26880903 |
US |
45 | 2 |
Drug dose omission by device, Device malfunction, |
||||
| 500 | 26880907 |
US |
40 | 2 |
Injection site pain, Injection site bruising, Device malfunction, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30